![]() | Up a level |
Darlow, Christopher A ORCID: 0000-0002-5400-3413, Docobo-Perez, Fernando, Farrington, Nicola, Johnson, Adam, McEntee, Laura, Unsworth, Jennifer, Jimenez-Valverde, Ana, Gastine, Silke, Dona, Ruwanthi Kolamunnage, de Costa, Renata MA et al (show 8 more authors)
(2021)
Amikacin Combined with Fosfomycin for Treatment of Neonatal Sepsis in the Setting of Highly Prevalent Antimicrobial Resistance.
Antimicrobial Agents and Chemotherapy.
Darlow, Christopher A ORCID: 0000-0002-5400-3413, Farrington, Nicola, Johnson, Adam, McEntee, Laura, Unsworth, Jennifer, Jimenez-Valverde, Ana, Kolamunnage-Dona, Ruwanthi
ORCID: 0000-0003-3886-6208, Da Costa, Renata MA, Ellis, Sally, Franceschi, Francois et al (show 5 more authors)
(2022)
Flomoxef and fosfomycin in combination for the treatment of neonatal sepsis in the setting of highly prevalent antimicrobial resistance.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 77 (5).
1334 - 1343.
Darlow, Christopher A ORCID: 0000-0002-5400-3413, da Costa, Renata MA, Ellis, Sally, Franceschi, Francois, Sharland, Mike, Piddock, Laura, Das, Shampa
ORCID: 0000-0002-2540-4816 and Hope, William
ORCID: 0000-0001-6187-878X
(2021)
Potential Antibiotics for the Treatment of Neonatal Sepsis Caused by Multidrug-Resistant Bacteria.
PEDIATRIC DRUGS, 23 (5).
465 - 484.